Wells Fargo Raises Kyverna Therapeutics (KYTX) PT to $27 on Confidence in KYV-101 Stiff Person Syndrome Trial Readout
Kyverna Therapeutics Inc. (NASDAQ:KYTX) is one of the best young stocks with huge upside potential.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | GordonMD Global Investments Craig Gordon | 4,244,818 | $36,632,779 | -4% | 25.51% |
| 2. | Deerfield Management James E. Flynn | 2,000,000 | $17,260,000 | 0.2% | |
| 3. | AIGH Investment Partners Orin Hirschman | 2,000,000 | $17,260,000 | +34% | 2.35% |
| 4. | Balyasny Asset Management Dmitry Balyasny | 1,125,321 | $9,711,520 | +15% | 0.01% |
| 5. | Millennium Management Israel Englander | 1,005,508 | $8,677,534 | +70% | 0% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.50 | 133,333 | $999,997.50 | 869,317 | 2025-12-18 | Filing | |
| $7.50 | 133,333 | $999,997.50 | 869,317 | 2025-12-18 | Filing | |
| $22.00 | 583 | $12,826.00 | 583 | 2024-02-12 | Filing | |
| $22.00 | 252,553 | $5,556,166.00 | 252,553 | 2024-02-12 | Filing | |
| $22.00 | 450,000 | $9,900,000.00 | 3,163,868 | 2024-02-12 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $12.20 | 23,998 | $292,775.60 | 22,636 | 2025-12-15 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,126,119 | $35,608,407 | 1.68% | |
| 2. | 3,110,000 | $26,839,300 | 2.42% | |
| 3. | 1,783,342 | $15,390,241 | 0% | |
| 4. | 989,054 | $8,535,536 | 0.6% | |
| 5. | 977,289 | $8,434,004 | 0% |